FACTOID # 19: Cheap sloppy joes: Looking for reduced-price lunches for schoolchildren? Head for Oklahoma!
 
 Home   Encyclopedia   Statistics   States A-Z   Flags   Maps   FAQ   About 
   
 
WHAT'S NEW
RELATED ARTICLES
People who viewed "AbioCor" also viewed:
 

SEARCH ALL

FACTS & STATISTICS    Advanced view

Search encyclopedia, statistics and forums:

 

 

(* = Graphable)

 

 


Encyclopedia > AbioCor

AbioCor is an artificial heart developed by the Massachusetts-based company AbioMed. It is fully implantable within a patient, due to a combination of advances in miniaturization, biosensors, plastics and energy transfer that has made this advance possible. The AbioCor runs on a rechargeable source of power and is being tested in clinical trials in preparation for approval by the Food and Drug Administration. An artificial heart is a device that is implanted into the body to replace the original biological heart. ... State nickname: Bay State Other U.S. States Capital Boston Largest city Boston Governor Mitt Romney (R) Official languages English Area 27,360 km² (44th)  - Land 20,317 km²  - Water 7,043 km² (25. ... The term plastics covers a range of synthetic or semi-synthetic polymerization products. ... Energy transfer is a term often used when describing terminal ballistics and stopping power. ... Rechargeable batteries are batteries that can be restored to full charge by the application of electrical energy. ... FDA logo The United States Food and Drug Administration (FDA) is the government agency responsible for regulating food (human and animal), dietary supplements, drugs (human and animal), cosmetics, medical devices (human and animal), biologics and blood products in the United States. ...


Testing

As of September 2004, 14 patients have been implanted with the AbioCor heart. Most of these patients have died. For a patient to be eligible for implantation with the AbioCor, the person must have severe heart failure (with failure of both ventricles) and must be likely to die within two weeks without transplantation. The first patient to receive the AbioCor, Robert Tools, was implanted on July 2, 2001. He lived for 151 days before having a fatal cerebrovascular accident. Tom Christerson lived for 512 days after receiving the AbioCor, dying on February 7, 2003. 2004 is a leap year starting on Thursday of the Gregorian calendar. ... In the heart, a ventricle is a chamber which collects blood from an atrium (another heart chamber) and pumps it out of the heart. ... An organ transplant is the transplantation of an organ (or part of one) from one body to another, for the purpose of replacing the recipients damaged or failing organ with a working one from the donor. ... July 2 is the 183rd day of the year (184th in leap years) in the Gregorian Calendar, with 182 days remaining. ... 2001: A Space Odyssey 2001 2001 is a common year starting on Monday of the Gregorian calendar. ... A stroke or cerebrovascular accident (CVA) occurs when the blood supply to a part of the brain is suddenly interrupted by occlusion (an ischemic stroke- approximately 90% of strokes), by hemorrhage (a hemorrhagic stroke - less than 10% of strokes) or other causes. ... February 7 is the 38th day of the year in the Gregorian Calendar. ... 2003 is a common year starting on Wednesday of the Gregorian calendar. ...


  Results from FactBites:
 
AbioCor - Wikipedia, the free encyclopedia (183 words)
AbioCor is an artificial heart developed by the Massachusetts-based company AbioMed.
The AbioCor runs on a rechargeable source of power and is being tested in clinical trials in preparation for approval by the Food and Drug Administration.
For a patient to be eligible for implantation with the AbioCor, the person must have severe heart failure (with failure of both ventricles) and must be likely to die within two weeks without transplantation.
AbioCor FAQ: Beth Israel Deaconess Medical Center - Boston, Hospital, abiocor, heart, artificial heart (1198 words)
The AbioCor is intended to replace the severely damaged natural heart and serve as an alternative to heart transplantation - the current method of saving patients with failing natural hearts.
The AbioCor is intended for use with patients who suffer from biventricular heart failure and for whom existing methods of surgical intervention or drug therapy are inadequate.
Equipped with an internal motor, the AbioCor is able to pump blood through the lungs and to the rest of the body, with a pulsatile flow that mimics the natural heart.
  More results at FactBites »

 
 

COMMENTARY     


Share your thoughts, questions and commentary here
Your name
Your comments

Want to know more?
Search encyclopedia, statistics and forums:

 


Press Releases |  Feeds | Contact
The Wikipedia article included on this page is licensed under the GFDL.
Images may be subject to relevant owners' copyright.
All other elements are (c) copyright NationMaster.com 2003-5. All Rights Reserved.
Usage implies agreement with terms, 1022, m